Current Report Filing (8-k)
2020年9月8日 - 9:31PM
Edgar (US Regulatory)
0001076682
false
false
0001076682
2020-09-02
2020-09-02
0001076682
PTE:CommonStockParValue0.001Member
2020-09-02
2020-09-02
0001076682
PTE:PreferredStockPurchaseRightsMember
2020-09-02
2020-09-02
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): September 2, 2020
POLARITYTE,
INC.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-32404
|
|
06-1529524
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
1960
S. 4250 West, Salt Lake City, UT 84104
(Address
of principal executive offices and zip code)
Registrant’s
telephone number, including area code: (800) 560-3983
(Former
name or former address, if changed since last report.)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol
|
|
Name
of each exchange on which registered
|
Common
Stock, Par Value $0.001
|
|
PTE
|
|
Nasdaq
Capital Market
|
Preferred
Stock Purchase Rights
|
|
|
|
Nasdaq
Capital Market
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐.
Item
1.01.
|
Entry
into a Material Definitive Agreement
|
On
September 2, 2020, Arches Research, Inc., a subsidiary of PolarityTE, Inc. (“Arches”) entered into two agreements
with Co-Diagnostics, Inc. (“Co-Diagnostics”).
The
COVID-19 Laboratory Services Agreement between the parties provides that Arches will perform specimen testing services for customers
referred by Co-Diagnostics to Arches. Co-Diagnostics will arrange all logistics for delivering specimens to Arches for COVID-19
testing for those customers of Co-Diagnostics electing to use the service. Arches bills Co-Diagnostics for the testing services
and Co-Diagnostics manages all customer billing.
The
Rental Agreement for LGC Genomics Oktopure Extraction Machine between Arches and Co-Diagnostics provides that Co-Diagnostics will
make available to Arches the Oktopure high throughput extraction machine that Arches will use to perform COVID-19 testing. The
term of the agreement is 12 months, requires Arches to use Co-Diagnostics tests exclusively in the machine, and establishes for
Arches a minimum monthly purchase obligation for Co-Diagnostics tests and related consumables used in the testing process.
On
September 8, 2020, the PolarityTE, Inc., issued a press release titled “PolarityTE Announces Strategic Partnership with
Co-Diagnostics to Expand COVID-19 Testing Platform,” a copy of which is attached to this report as an exhibit.
Item
9.01
|
Financial
Statements and Exhibits.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
POLARITYTE,
INC.
|
|
|
Dated:
September 8, 2020
|
/s/
Jacob Patterson
|
|
Jacob
Patterson
|
|
Interim
Chief Financial Officer
|
PolarityTE (NASDAQ:PTE)
過去 株価チャート
から 6 2024 まで 7 2024
PolarityTE (NASDAQ:PTE)
過去 株価チャート
から 7 2023 まで 7 2024